Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones
Maria Voura, Parvez Κhan, Savvas Thysiadis, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

A Near‐Infrared Light‐Activated Photocage Based on a Ruthenium Complex for Cancer Phototherapy
Guangli He, Maomao He, Ran Wang, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 24
Closed Access | Times Cited: 55
Investigation of inhibitory potential of quercetin to the pyruvate dehydrogenase kinase 3: Towards implications in anticancer therapy
Rashmi Dahiya, Taj Mohammad, Sonam Roy, et al.
International Journal of Biological Macromolecules (2019) Vol. 136, pp. 1076-1085
Closed Access | Times Cited: 95
MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy
Anas Shamsi, Saleha Anwar, Taj Mohammad, et al.
Biomolecules (2020) Vol. 10, Iss. 5, pp. 789-789
Open Access | Times Cited: 95
Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant
Elaine Cristina Dalazen Gonçalves, Gabriela Mantovani Baldasso, Maíra A. Bicca, et al.
Molecules (2020) Vol. 25, Iss. 7, pp. 1567-1567
Open Access | Times Cited: 90
Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapy
Preeti Gupta, Taj Mohammad, Parvez Κhan, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 118, pp. 109245-109245
Open Access | Times Cited: 88
Discovery of Hordenine as a Potential Inhibitor of Pyruvate Dehydrogenase Kinase 3: Implication in Lung Cancer Therapy
Saleha Anwar, Taj Mohammad, Anas Shamsi, et al.
Biomedicines (2020) Vol. 8, Iss. 5, pp. 119-119
Open Access | Times Cited: 86
Identification of α-Mangostin as a Potential Inhibitor of Microtubule Affinity Regulating Kinase 4
Parvez Κhan, Aarfa Queen, Taj Mohammad, et al.
Journal of Natural Products (2019) Vol. 82, Iss. 8, pp. 2252-2261
Closed Access | Times Cited: 73
Inhibiting CDK6 Activity by Quercetin Is an Attractive Strategy for Cancer Therapy
Mohd Yousuf, Parvez Κhan, Anas Shamsi, et al.
ACS Omega (2020) Vol. 5, Iss. 42, pp. 27480-27491
Open Access | Times Cited: 66
Structure‐based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases
Saleha Anwar, Shama Khan, Anas Shamsi, et al.
Journal of Cellular Biochemistry (2021) Vol. 122, Iss. 10, pp. 1445-1459
Closed Access | Times Cited: 53
Targeting Tau Hyperphosphorylation via Kinase Inhibition: Strategy to Address Alzheimer's Disease
Ahmad Abu Turab Naqvi, Gulam Mustafa Hasan, Md. Imtaiyaz Hassan
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 12, pp. 1059-1073
Closed Access | Times Cited: 51
Identification of Sphingosine Kinase-1 Inhibitors from Bioactive Natural Products Targeting Cancer Therapy
Deeba Shamim Jairajpuri, Taj Mohammad, Kirtika Adhikari, et al.
ACS Omega (2020) Vol. 5, Iss. 24, pp. 14720-14729
Open Access | Times Cited: 49
Investigating neuroprotective roles of Bacopa monnieri extracts: Mechanistic insights and therapeutic implications
Urooj Fatima, Sonam Roy, Shahnawaz Ahmad, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113469-113469
Closed Access | Times Cited: 34
Molecular interaction studies on ellagic acid for its anticancer potential targeting pyruvate dehydrogenase kinase 3
Rashmi Dahiya, Taj Mohammad, Preeti Gupta, et al.
RSC Advances (2019) Vol. 9, Iss. 40, pp. 23302-23315
Open Access | Times Cited: 48
Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer
Sonam Roy, Taj Mohammad, Preeti Gupta, et al.
ACS Omega (2020) Vol. 5, Iss. 34, pp. 21550-21560
Open Access | Times Cited: 47
Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: Towards therapeutic management of Alzheimer’s disease
Ahmad Abu Turab Naqvi, Deeba Shamim Jairajpuri, Omar M. Noman, et al.
Journal of Biomolecular Structure and Dynamics (2019) Vol. 38, Iss. 13, pp. 3892-3907
Closed Access | Times Cited: 44
Targets and pathways involved in the antitumor activity of citral and its stereo-isomers
Christian Bailly
European Journal of Pharmacology (2020) Vol. 871, pp. 172945-172945
Closed Access | Times Cited: 42
Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: Towards therapeutic implications in neurodegenerative diseases
Saleha Anwar, Anas Shamsi, Rajiv K. Kar, et al.
International Journal of Biological Macromolecules (2020) Vol. 161, pp. 596-604
Closed Access | Times Cited: 40
Targeting cyclin‐dependent kinase 6 by vanillin inhibits proliferation of breast and lung cancer cells: Combined computational and biochemical studies
Mohd Yousuf, Anas Shamsi, Aarfa Queen, et al.
Journal of Cellular Biochemistry (2021) Vol. 122, Iss. 8, pp. 897-910
Closed Access | Times Cited: 32
A comprehensive review on acridone based derivatives as future anti-cancer agents and their structure activity relationships
Tanuja Yadav, Manikanta Murahari, Godefridus J. Peters, et al.
European Journal of Medicinal Chemistry (2022) Vol. 239, pp. 114527-114527
Closed Access | Times Cited: 26
Design, synthesis & biological evaluation of ferulic acid-based small molecule inhibitors against tumor-associated carbonic anhydrase IX
Babita Aneja, Aarfa Queen, Parvez Κhan, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 28, Iss. 9, pp. 115424-115424
Closed Access | Times Cited: 33
Implications of tempol in pyruvate dehydrogenase kinase 3 targeted anticancer therapeutics: Computational, spectroscopic, and calorimetric studies
Saleha Anwar, Debarati DasGupta, Alaa Shafie, et al.
Journal of Molecular Liquids (2022) Vol. 350, pp. 118581-118581
Closed Access | Times Cited: 20
Microtubule-affinity regulating kinase 4: A potential drug target for cancer therapy
Saleha Anwar, Moyad Shahwan, Gulam Mustafa Hasan, et al.
Cellular Signalling (2022) Vol. 99, pp. 110434-110434
Closed Access | Times Cited: 18
A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy: Targeting MARK4 for Hepatocellular Carcinoma
Sarfraz Ahmed, Mohammad Mobashir, Lamya Ahmed Al‐Keridis, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Therapeutic targeting of microtubule affinity‐regulating kinase 4 in cancer and neurodegenerative diseases
Manzar Alam, Sarfraz Ahmed, Mohammad Abid, et al.
Journal of Cellular Biochemistry (2023) Vol. 124, Iss. 9, pp. 1223-1240
Open Access | Times Cited: 9
Probing Baicalin as potential inhibitor of Aurora kinase B: A step towards lung cancer therapy
Saba Noor, Arunabh Choudhury, Ali Raza, et al.
International Journal of Biological Macromolecules (2023) Vol. 258, pp. 128813-128813
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top